Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy - Wikidata - awgldk - TriplyDB

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

http://www.wikidata.org/entity/Q28572974

about

Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protection Sympathetic nervous system overactivity and its role in the development of cardiovascular disease Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial.

P2860

Q27002648-3B422896-C762-4FFA-BED3-DEF5C4824257 Q28279754-6F882BDB-3C4D-4DA7-8D76-466F41B1CA36 Q43169808-229FF3E3-5D0E-4B6E-BF57-88471C1C4CE8

P2860

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

http://www.wikidata.org/entity/Q28572974

description

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2004

@ast

im Juli 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2004/07/01)

@sk

vědecký článek publikovaný v roce 2004

@cs

wetenschappelijk artikel (gepubliceerd op 2004/07/01)

@nl

наукова стаття, опублікована в липні 2004

@uk

مقالة علمية (نشرت في يوليو 2004)

@ar

name

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@ast

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@en

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@nl

type

label

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@ast

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@en

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@nl

prefLabel

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@ast

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@en

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@nl

P1433

Q28572974-02209907-66F2-4374-AF63-E53EAA548127

P1476

Q28572974-8BB1FE86-30D7-4988-B184-C3ECF67E034A

P2093

Q28572974-12EEB016-111B-4703-AB6E-4551C93947C7

Q28572974-4B38AF6A-6BA2-4062-98EC-75650B8FD7E4

Q28572974-D2A4DB40-47BF-4B51-8694-F2A1C3473DE4

Q28572974-EF313223-0467-4553-8AD4-1B078EF5DA04

P2860

Q28572974-1F2BAAC9-C09D-40FC-BBB2-141EB24EB7CD

Q28572974-4A4B5079-C760-4E0B-A7E4-E8F6ED3250DC

Q28572974-702C3B40-11F3-4A5C-925C-3EF7D90A1D41

Q28572974-8286989C-1C9B-49A5-81D3-A8CF3906F576

Q28572974-8658AB52-40A1-434D-893D-42969EB0AF24

Q28572974-867419C9-0C99-4353-82D2-C6FEA745194B

Q28572974-90BBB9D0-4437-4BEF-94A9-12B6E79E5E52

Q28572974-99BD115E-D2FF-49AE-A01D-D30EEC237722

Q28572974-BC0CD661-9ADA-4876-B6B3-C0E9E50555D6

Q28572974-E87C6460-820B-4FA6-B6AF-709847B8D7F0

P304

Q28572974-B35E0E52-F480-4E70-AAAC-88B37638559F

P31

Q28572974-4510733C-CED1-4464-9E39-810A63D45803

P356

Q28572974-D0775D7D-217A-4D35-92CA-F3A39C081903

P433

Q28572974-DD4A6972-9857-48F2-9B89-4F1CDD0596E7

P478

Q28572974-972F3A64-8CA4-4DB8-8D8B-7063B2BE2537

P577

Q28572974-A066F9BE-EF35-4D8F-9557-0E5279668903

P5875

Q28572974-DBE266B3-7C1E-4A49-8BC1-CAFB4451A1B5

P698

Q28572974-17E427AE-E8F9-4DAD-B049-FDF1211E09AD

P356

AJPHEART.00977.2003

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

@en

P2093

Chang Won Kang

http://www.w3.org/2001/XMLSchema#string

Chunhua Cao

http://www.w3.org/2001/XMLSchema#string

Suhn Hee Kim

http://www.w3.org/2001/XMLSchema#string

Sung Zoo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Peripheral and central imidazoline receptor-mediated natriuresis in the rat.

Imidazoline receptors in the heart: characterization, distribution, and regulation.

Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.

Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion.

Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.

I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives.

The renal actions of moxonidine are mediated by atrial natriuretic peptide and involve the opioid receptors.

Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C.

Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes.

Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells.

P304

H150–156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00977.2003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5887396

http://www.w3.org/2001/XMLSchema#string

P698

14975931

http://www.w3.org/2001/XMLSchema#string